Skip to content

To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty

Prospective Multicentre Longitudinal Study to Evaluate the Safety and Clinical Radiological Outcomes in the First Two Years of the Ambrace Model Reverse Shoulder Arthroplasty.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05569161
Enrollment
250
Registered
2022-10-06
Start date
2022-03-24
Completion date
2026-10-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implantation of a Reverse Shoulder Prosthesis

Brief summary

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. The aim is to carry out a more detailed follow-up of the subjects who are implanted with this prosthetic model on a primary basis, analysing the clinical and radiological results and evaluating the presence of adverse effects of the prosthesis or short-term complications. For this purpose, subjects will be closely monitored for two years.

Detailed description

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. However, there are complications associated with shoulder arthroplasty surgery, such as wear of the prosthetic components, infection, allergy to the prosthetic components, or failure to restore full shoulder function. The occurrence of these complications is affected by multiple factors dependent on the subject, the surgeon and/or the implant used.

Interventions

None listed

Sponsors

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who, after receiving information about the study design, the aims of the study, the possible risks that may arise from it and the fact that they may refuse to participate at any time, give their written consent to participate in the study. * Be over 18 years of age. * Have a shoulder joint disorder that is amenable to treatment with an Embrace reverse arthroplasty. * Have a CT or MRI scan performed no more than 6 months prior to surgery. Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

* Patients who have undergone arthroplasty of any type on the ipsilateral shoulder. * Patients with an active infection at any site at the time of shoulder surgery.

Design outcomes

Primary

MeasureTime frameDescription
To assess the safety and the clinical and radiological outcome of Embrace primary reverse shoulder prostheses.24 monthssurvival at 2-year follow-up with computerized tomografhic

Secondary

MeasureTime frameDescription
security24 monthspresence of possible adverse effects or complications, implant-related or not, including infection, mechanical complications of the implant, dislocation, fracture, loosening, readmission, reoperation or fracture.
efficiency24 monthsTo evaluate the effect of the Embrace Reverse Embrace arthroplasty on postoperative pain and functional outcome. This is evaluate with computerized tomographic.

Countries

Spain

Contacts

Primary ContactMiguel Ángel Ruiz Iban, MD, PhD
drmri@gmail.com655668479

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026